Signify Health, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000182818222000029 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$451.3M	$756.5M
YoY Change	-40.34%
Cash & Equivalents	$451.3M	$756.5M
Short-Term Investments
Other Short-Term Assets	$21.40M	$16.10M
YoY Change	32.92%
Inventory
Prepaid Expenses
Receivables	$220.7M	$169.4M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$825.9M	$1.003B
YoY Change	-17.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.40M	$24.10M
YoY Change	-2.9%
Goodwill	$796.4M	$596.7M
YoY Change	33.47%
Intangibles	$540.2M	$497.9M
YoY Change	8.5%
Long-Term Investments
YoY Change
Other Assets	$10.70M	$5.700M
YoY Change	87.72%
Total Long-Term Assets	$1.446B	$1.169B
YoY Change	23.61%
TOTAL ASSETS
Total Short-Term Assets	$825.9M	$1.003B
Total Long-Term Assets	$1.446B	$1.169B
Total Assets	$2.271B	$2.173B
YoY Change	4.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.500M	$9.400M
YoY Change	-30.85%
Accrued Expenses	$61.60M	$49.30M
YoY Change	24.95%
Deferred Revenue	$2.600M	$7.000M
YoY Change	-62.86%	337.5%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.500M	$4.200M
YoY Change	-16.67%
Total Short-Term Liabilities	$171.3M	$191.5M
YoY Change	-10.55%
LONG-TERM LIABILITIES
Long-Term Debt	$334.5M	$396.8M
YoY Change	-15.7%
Other Long-Term Liabilities	$1.200M	$16.70M
YoY Change	-92.81%
Total Long-Term Liabilities	$335.7M	$413.5M
YoY Change	-18.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$171.3M	$191.5M
Total Long-Term Liabilities	$335.7M	$413.5M
Total Liabilities	$725.5M	$741.7M
YoY Change	-2.18%
SHAREHOLDERS EQUITY
Retained Earnings	$8.400M	-$23.20M
YoY Change	-136.21%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.171B	$1.061B
YoY Change
Total Liabilities & Shareholders Equity	$2.271B	$2.173B
YoY Change	4.54%

Cashflow Statement

Concept	2022 Q1	2021 Q1

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001828182
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-40028
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	Signify Health, Inc.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3481223
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	800 Connecticut Avenue
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Norwalk
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06854
CY2022Q1	dei	City Area Code CityAreaCode	203
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	541-4600
CY2022Q1	dei	Security12b Title Security12bTitle	Class A common stock, par value $0.01 per Share
CY2022Q1	dei	Trading Symbol TradingSymbol	SGFY
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	451300000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	678500000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	220700000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	217200000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	132500000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	84300000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2300000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5700000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19100000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14900000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	825900000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1000600000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23400000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23700000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	796400000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	597100000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	540200000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	455300000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21300000	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	53500000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	38800000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10700000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11700000	USD
CY2022Q1	us-gaap	Assets Assets	2271400000	USD
CY2021Q4	us-gaap	Assets Assets	2127200000	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	105500000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	136700000	USD
CY2022Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	44000000.0	USD
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	32900000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3500000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3500000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	18300000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10000000.0	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	171300000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	183100000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	334500000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	334900000	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	30600000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
CY2022Q1	sgfy	Stock Appreciation Rights Liability StockAppreciationRightsLiability	84000000.0	USD
CY2022Q1	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	56300000	USD
CY2021Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	56300000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	22400000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	25200000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1200000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11400000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	725500000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	634300000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1160000000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1101300000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8400000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	19700000	USD
CY2022Q1	us-gaap	Minority Interest MinorityInterest	375100000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	369600000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1545900000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1492900000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2271400000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2127200000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	216500000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	180000000.0	USD
CY2022Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	114500000	USD
CY2021Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	98500000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	70300000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	57300000	USD
CY2022Q1	sgfy	Transaction Related Expenses TransactionRelatedExpenses	3200000	USD
CY2021Q1	sgfy	Transaction Related Expenses TransactionRelatedExpenses	5600000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	18000000.0	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	16700000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	206000000.0	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	178100000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	10500000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1900000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	4000000.0	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	6800000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-28800000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-56700000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-32800000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-63500000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22300000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-61600000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6000000.0	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9900000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-16300000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-51700000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-17200000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5400000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11300000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-10900000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-23200000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	172761665	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165486015	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	172761665	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	165486015	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1492900000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6600000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1600000	USD
CY2022Q1	sgfy	Noncontrolling Interest Tax Payments On Behalf Of Non Controlling Interest NoncontrollingInterestTaxPaymentsOnBehalfOfNonControllingInterest	300000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	61800000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-16300000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1545900000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	894000000.0	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-17200000	USD
CY2021Q1	us-gaap	Limited Liability Company Llc Members Equity Unit Based Compensation LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation	900000	USD
CY2021Q1	sgfy	Stock Issued During Period Value Effect Of Reorganization Transactions StockIssuedDuringPeriodValueEffectOfReorganizationTransactions	0	USD
CY2021Q1	sgfy	Adjustments To Additional Paid In Capital Contributions AdjustmentsToAdditionalPaidInCapitalContributions	26000000.0	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	604900000	USD
CY2021Q1	sgfy	Adjustments To Additional Paid In Capital Deferred Tax Adjustment AdjustmentsToAdditionalPaidInCapitalDeferredTaxAdjustment	6300000	USD
CY2021Q1	sgfy	Adjustments To Additional Paid In Capital Subscription Fee Receivable AdjustmentsToAdditionalPaidInCapitalSubscriptionFeeReceivable	600000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1600000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	400000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-34500000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1431000000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-16300000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-51700000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18000000.0	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16700000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6600000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2500000	USD
CY2022Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	6500000	USD
CY2021Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	4900000	USD
CY2022Q1	sgfy	Fair Value Adjustment Of Share Based Compensation Agreement Granted For Services FairValueAdjustmentOfShareBasedCompensationAgreementGrantedForServices	28900000	USD
CY2021Q1	sgfy	Fair Value Adjustment Of Share Based Compensation Agreement Granted For Services FairValueAdjustmentOfShareBasedCompensationAgreementGrantedForServices	56800000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	600000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	700000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1700000	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	100000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	200000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12900000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-14000000.0	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1900000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-101200000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2300000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2400000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	39100000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	33500000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1300000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1000000.0	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-32100000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-13800000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	11100000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	14600000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-700000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1900000	USD
CY2022Q1	sgfy	Increase Decrease In Noncurrent Lease Liabilities IncreaseDecreaseInNoncurrentLeaseLiabilities	-1900000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	100000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1200000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-32300000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	86700000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1700000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	700000	USD
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	6800000	USD
CY2021Q1	us-gaap	Payments For Software PaymentsForSoftware	5700000	USD
CY2022Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	300000	USD
CY2021Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	189600000	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-198400000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6400000	USD
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	900000	USD
CY2021Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1000000.0	USD
CY2022Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	300000	USD
CY2021Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	300000	USD
CY2022Q1	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid	300000	USD
CY2021Q1	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid	0	USD
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	604800000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1600000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	100000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	100000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	603600000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-230600000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	683900000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	684200000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77000000.0	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	453600000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	760900000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	3300000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	4800000	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-100000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	900000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	600000	USD
CY2022Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2021Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	26000000.0	USD
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	60000000.0	USD
CY2021Q1	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2022Q1	sgfy	Establishment Of Liabilities Under Tax Receivable Agreement EstablishmentOfLiabilitiesUnderTaxReceivableAgreement	-100000	USD
CY2021Q1	sgfy	Establishment Of Liabilities Under Tax Receivable Agreement EstablishmentOfLiabilitiesUnderTaxReceivableAgreement	0	USD
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accompanying Condensed Consolidated Financial Statements have been prepared in conformity with GAAP, which requires management to make estimates and assumptions affecting the reported amounts in our Condensed Consolidated Financial Statements and accompanying notes. These estimates are based on information available as of the date of the Condensed Consolidated Financial Statements; therefore, actual results could differ from those estimates. The significant estimates underlying our Condensed Consolidated Financial Statements include revenue recognition; allowance for doubtful accounts; recoverability of long-lived assets, intangible assets and goodwill; loss contingencies; accounting for business combinations, including amounts assigned to definite and indefinite lived intangible assets and contingent consideration; customer equity appreciation rights; and equity-based compensation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March 31, 2022, the COVID-19 pandemic continues to evolve and impact our Episodes of Care Services segment due to the passage of time between episode initiation and the performance and subsequent recognition of revenue for our services; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">See</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Note 3 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The COVID-19 Pandemic</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. As a result, many of our estimates and assumptions have required increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, our estimates may change materially in the future.</span></div>
CY2022Q1	sgfy	Restricted Cash Agreement Return Of Funds Following Conclusion Of Effective Period Period RestrictedCashAgreementReturnOfFundsFollowingConclusionOfEffectivePeriodPeriod	P18M
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	451300000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	678500000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2300000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5700000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	453600000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	684200000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	9700000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7900000	USD
CY2022Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	200000	USD
CY2021Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	300000	USD
CY2021Q4	sgfy	Number Of Physician Practices NumberOfPhysicianPractices	7	physicianPractice
CY2022Q1	sgfy	Number Of Physician Practices NumberOfPhysicianPractices	7	physicianPractice
CY2022Q1	sgfy	Number Of Variable Interest Entities NumberOfVariableInterestEntities	4	accountable_care_organization
CY2022Q1	sgfy	Variable Interest Entity Minimum Requirement Of Aco Participants Percent VariableInterestEntityMinimumRequirementOfACOParticipantsPercent	0.75
CY2022Q1	sgfy	Number Of Variable Interest Entities Number Of Entities Liable For Losses NumberOfVariableInterestEntitiesNumberOfEntitiesLiableForLosses	1	accountable_care_organization
CY2022Q1	sgfy	Number Of Variable Interest Entities NumberOfVariableInterestEntities	4	accountable_care_organization
CY2022Q1	sgfy	Number Of Variable Interest Entities Number Of Entities Not Part Of Mssp Model NumberOfVariableInterestEntitiesNumberOfEntitiesNotPartOfMSSPModel	2	accountable_care_organization
CY2022Q1	sgfy	Number Of Variable Interest Entities NumberOfVariableInterestEntities	4	accountable_care_organization
CY2022Q1	sgfy	Variable Interest Entity Minimum Shared Loss Rate Percent VariableInterestEntityMinimumSharedLossRatePercent	0.02
CY2022Q1	sgfy	Variable Interest Entity Losses Calculated Minimum Shared Loss Rate Percent VariableInterestEntityLossesCalculatedMinimumSharedLossRatePercent	0.40
CY2022Q1	sgfy	Variable Interest Entity Maximum Shared Loss Rate Percent VariableInterestEntityMaximumSharedLossRatePercent	0.75
CY2022Q1	sgfy	Variable Interest Entity Maximum Updated Benchmark Percent VariableInterestEntityMaximumUpdatedBenchmarkPercent	0.15
CY2022Q1	sgfy	Variable Interest Entity Percent Of Potential Losses Bearing Risk VariableInterestEntityPercentOfPotentialLossesBearingRisk	0.01
CY2022Q1	sgfy	Variable Interest Entity Mssp Maximum Percent VariableInterestEntityMSSPMaximumPercent	0.15
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	216500000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	180000000.0	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	220700000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	217200000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	132500000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	84300000	USD
CY2022Q1	sgfy	Shared Savings Payable SharedSavingsPayable	37400000	USD
CY2021Q4	sgfy	Shared Savings Payable SharedSavingsPayable	63400000	USD
CY2022Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	44000000.0	USD
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	32900000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2600000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3600000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	84300000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	27800000	USD
CY2022Q1	sgfy	Contract With Customer Asset Acquired In Business Acquisition ContractWithCustomerAssetAcquiredInBusinessAcquisition	9100000	USD
CY2021Q1	sgfy	Contract With Customer Asset Acquired In Business Acquisition ContractWithCustomerAssetAcquiredInBusinessAcquisition	0	USD
CY2022Q1	sgfy	Contract With Customer Asset Performance Obligation Satisfied In Period At Point In Time ContractWithCustomerAssetPerformanceObligationSatisfiedInPeriodAtPointInTime	2900000	USD
CY2021Q1	sgfy	Contract With Customer Asset Performance Obligation Satisfied In Period At Point In Time ContractWithCustomerAssetPerformanceObligationSatisfiedInPeriodAtPointInTime	0	USD
CY2022Q1	sgfy	Contract With Customer Asset Performance Obligation Satisfied In Period ContractWithCustomerAssetPerformanceObligationSatisfiedInPeriod	36200000	USD
CY2021Q1	sgfy	Contract With Customer Asset Performance Obligation Satisfied In Period ContractWithCustomerAssetPerformanceObligationSatisfiedInPeriod	33500000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	132500000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	61300000	USD
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	32900000	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	6200000	USD
CY2022Q1	sgfy	Contract With Customer Refund Liability Payments Made To Customer ContractWithCustomerRefundLiabilityPaymentsMadeToCustomer	0	USD
CY2021Q1	sgfy	Contract With Customer Refund Liability Payments Made To Customer ContractWithCustomerRefundLiabilityPaymentsMadeToCustomer	600000	USD
CY2022Q1	sgfy	Contract With Customer Refund Liability Performance Obligations Satisfied At Point In Time ContractWithCustomerRefundLiabilityPerformanceObligationsSatisfiedAtPointInTime	-300000	USD
CY2021Q1	sgfy	Contract With Customer Refund Liability Performance Obligations Satisfied At Point In Time ContractWithCustomerRefundLiabilityPerformanceObligationsSatisfiedAtPointInTime	1100000	USD
CY2022Q1	sgfy	Contract With Customer Refund Liability Performance Obligation Satisfied In Period ContractWithCustomerRefundLiabilityPerformanceObligationSatisfiedInPeriod	11400000	USD
CY2021Q1	sgfy	Contract With Customer Refund Liability Performance Obligation Satisfied In Period ContractWithCustomerRefundLiabilityPerformanceObligationSatisfiedInPeriod	14100000	USD
CY2022Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	44000000.0	USD
CY2021Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	20800000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3600000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3800000	USD
CY2022Q1	sgfy	Contract With Customer Liability Acquired In Business Combination ContractWithCustomerLiabilityAcquiredInBusinessCombination	500000	USD
CY2021Q1	sgfy	Contract With Customer Liability Acquired In Business Combination ContractWithCustomerLiabilityAcquiredInBusinessCombination	0	USD
CY2022Q1	sgfy	Contract With Customer Liability Payments Received From Customers ContractWithCustomerLiabilityPaymentsReceivedFromCustomers	600000	USD
CY2021Q1	sgfy	Contract With Customer Liability Payments Received From Customers ContractWithCustomerLiabilityPaymentsReceivedFromCustomers	7500000	USD
CY2022Q1	sgfy	Contract With Customer Liability Deferred Revenue Recognized ContractWithCustomerLiabilityDeferredRevenueRecognized	2100000	USD
CY2021Q1	sgfy	Contract With Customer Liability Deferred Revenue Recognized ContractWithCustomerLiabilityDeferredRevenueRecognized	4300000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2600000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7000000.0	USD
CY2021Q4	sgfy	Shared Savings Payable SharedSavingsPayable	63400000	USD
CY2020Q4	sgfy	Shared Savings Payable SharedSavingsPayable	80800000	USD
CY2022Q1	sgfy	Shared Savings Payable Payments To Customer SharedSavingsPayablePaymentsToCustomer	67800000	USD
CY2021Q1	sgfy	Shared Savings Payable Payments To Customer SharedSavingsPayablePaymentsToCustomer	22000000.0	USD
CY2022Q1	sgfy	Shared Savings Payable Due To Customer Performance Obligation Satisfied SharedSavingsPayableDueToCustomerPerformanceObligationSatisfied	41800000	USD
CY2021Q1	sgfy	Shared Savings Payable Due To Customer Performance Obligation Satisfied SharedSavingsPayableDueToCustomerPerformanceObligationSatisfied	15600000	USD
CY2022Q1	sgfy	Shared Savings Payable SharedSavingsPayable	37400000	USD
CY2021Q1	sgfy	Shared Savings Payable SharedSavingsPayable	74400000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	51900000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	50200000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	28500000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26500000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23400000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23700000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	2200000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	2000000.0	USD
CY2021Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2022Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23000000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	35600000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2021Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	12200000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	19700000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21300000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8100000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	25200000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	33300000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2700000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2100000	USD
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	700000	USD
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	700000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	2100000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y9M18D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.046
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	7200000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8300000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4800000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4100000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3400000	USD
CY2022Q1	sgfy	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	10600000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	38400000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5100000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	33300000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	10200000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	8700000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	6100000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	9300000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	8600000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	21500000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	64400000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	53400000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	65400000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50600000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	765500000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	225300000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	540200000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	664800000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	209500000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	455300000	USD
CY2022Q1	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	6800000	USD
CY2021Q1	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	5700000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15800000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14700000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	43800000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	43100000	USD
CY2022Q1	sgfy	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	283900000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	540200000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	597100000	USD
CY2022Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	199300000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	796400000	USD
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2022Q1	sgfy	Shared Savings Payable SharedSavingsPayable	37400000	USD
CY2021Q4	sgfy	Shared Savings Payable SharedSavingsPayable	63400000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	28600000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	46500000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	25200000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	19600000	USD
CY2022Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	7800000	USD
CY2021Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	1600000	USD
CY2022Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	6500000	USD
CY2021Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	5600000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3500000	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	105500000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	136700000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	348300000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	349100000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5800000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6000000.0	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4500000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4700000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	338000000.0	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	338400000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3500000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	334500000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	334900000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	2600000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3500000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3500000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3500000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3500000	USD
CY2022Q1	sgfy	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	331700000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	348300000	USD
CY2021Q1	sgfy	Number Of Classes Of Common Stock NumberOfClassesOfCommonStock	2	class
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-16300000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-51700000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-17200000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5400000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11300000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-10900000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-23200000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	172761665	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165486015	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3200000	USD
CY2021Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	900000	USD
CY2022Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	12200000	USD
CY2022Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1800000	USD
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1600000	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	30600000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6000000.0	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9900000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.270
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.161
CY2022Q1	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	300000	USD
CY2021Q1	sgfy	Tax Receivable Agreement Applicable Cash Savings Payable Percent TaxReceivableAgreementApplicableCashSavingsPayablePercent	0.85
CY2021Q1	sgfy	Tax Receivable Agreement Applicable Cash Savings Retainable Percent TaxReceivableAgreementApplicableCashSavingsRetainablePercent	0.15
CY2022Q1	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	56300000	USD
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q1	sgfy	Unallocated Costs And Expenses UnallocatedCostsAndExpenses	45300000	USD
CY2021Q1	sgfy	Unallocated Costs And Expenses UnallocatedCostsAndExpenses	72500000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18000000.0	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16700000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	4000000.0	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	6800000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22300000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-61600000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-28800000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-56700000	USD
CY2022Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	3200000	USD
CY2021Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	5600000	USD
CY2022Q1	sgfy	Non Allocated Costs And Expenses NonAllocatedCostsAndExpenses	200000	USD
CY2021Q1	sgfy	Non Allocated Costs And Expenses NonAllocatedCostsAndExpenses	1300000	USD
CY2022Q1	sgfy	Unallocated Costs And Expenses UnallocatedCostsAndExpenses	45300000	USD
CY2021Q1	sgfy	Unallocated Costs And Expenses UnallocatedCostsAndExpenses	72500000	USD

Files In Submission

Name	View Source	Status
0001828182-22-000029-index-headers.html	Edgar Link	pending
0001828182-22-000029-index.html	Edgar Link	pending
0001828182-22-000029.txt	Edgar Link	pending
0001828182-22-000029-xbrl.zip	Edgar Link	pending
exhibit101033122.htm	Edgar Link	pending
exhibit102033122.htm	Edgar Link	pending
exhibit103033122.htm	Edgar Link	pending
exhibit104033122.htm	Edgar Link	pending
exhibit105033122armbrester.htm	Edgar Link	pending
exhibit106033122boumenotb.htm	Edgar Link	pending
exhibit107033122boumenotc.htm	Edgar Link	pending
exhibit108033122builder.htm	Edgar Link	pending
exhibit311033122.htm	Edgar Link	pending
exhibit312033122.htm	Edgar Link	pending
exhibit321033122.htm	Edgar Link	pending
exhibit322033122.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_01.jpg	Edgar Link	pending
image_02.jpg	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_11a.jpg	Edgar Link	pending
image_13.jpg	Edgar Link	pending
image_14.jpg	Edgar Link	pending
image_1b.jpg	Edgar Link	pending
image_21.jpg	Edgar Link	pending
image_31a.jpg	Edgar Link	pending
image_32.jpg	Edgar Link	pending
image_33.jpg	Edgar Link	pending
image_3a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgfy-20220331.htm	Edgar Link	pending
sgfy-20220331.xsd	Edgar Link	pending
sgfy-20220331_cal.xml	Edgar Link	unprocessable
sgfy-20220331_def.xml	Edgar Link	unprocessable
sgfy-20220331_htm.xml	Edgar Link	completed
sgfy-20220331_lab.xml	Edgar Link	unprocessable
sgfy-20220331_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Signify Health, Inc.

2022 Q1 Form 10-Q Financial Statement

#000182818222000029 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission